Taiyixin has developed 99.99% ultra-high purity Emamectin Benzoate

On April 18, 2024, Ningxia Taiyixin’s R & D laboratory announced that it has successfully developed China's ultra-high purity Emamectin Benzoate, quality indicators: The mass fraction of Emamectin Benzoate (B1a+B1b) is 99.99%, and the ratio of B1a+B1b is more than 250.

Tai Yixin has always been committed to the research and development, production and sales of biological fermentation antibiotics. The main products are Emamectin Benzoate and Avermectin, and the whole industry chain layout. It has successively developed opalescent, non-degradable Avermectin, patent leading, good crystal and high activity Emamectin Benzoate technical, and continuously expanded EC, WDG, WSG, SC, ME and a series of preparation products to meet market demand.

Taiyixin pays attention to the construction of independent innovation capacity, makes a clear medium - and long-term plan around scientific research work, and carries out comprehensive integration and secondary development of existing scientific and technological achievements. After continuous scientific and technological investment and technological research, the company successfully produced China's "ultra-high purity Emamectin Benzoate", marking the development and production of Taiyixin pesticide into a new milestone.

Ningxia Taiyixin, as an intelligent world brand enterprise, will comply with the purpose of "creating social wealth, serving health", adhering to the business policy of "talent as the foundation, marketing as the leader, scientific research as the backing, management as the main line", and adhere to the enterprise spirit of "innovation, cooperation, harmony and win-win". On the basis of making full use of the regional advantages of Ningxia, based on a high starting point, pay attention to the development of high-tech biological products with international advanced level and consistent quality, and strive to build a world-class antibiotic biological fermentation industry base.